Evidence map›Paper›PMID 28842509›Full record

ArticleRNA (New York, N.Y.)2017

An improved analysis methodology for translational profiling by microarray.

Thomas Sbarrato, Ruth V Spriggs, Lindsay Wilson, Carolyn Jones, Kate Dudek, Amandine Bastide, Xavier Pichon, Tuija Pöyry, Anne E Willis

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thomas SbarratoMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom thomas.sbarrato@inserm.fr rvs3@leicester.ac.uk.
Ruth V SpriggsMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.
Lindsay WilsonMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.
Carolyn JonesMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.
Kate DudekMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.
Amandine BastideMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.
Xavier PichonMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.
Tuija PöyryMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.
Anne E WillisMedical Research Council Toxicology Unit, Leicester LE1 9HN, United Kingdom.

Funding

Medical Research Council MC_UP_A600_1023Wellcome Trust
6 · The paper itself

Abstract

Translational regulation plays a central role in the global gene expression of a cell, and detection of such regulation has allowed deciphering of critical biological mechanisms. Genome-wide studies of the regulation of translation (translatome) performed on microarrays represent a substantial proportion of studies, alongside with recent advances in deep-sequencing methods. However, there has been a lack of development in specific processing methodologies that deal with the distinct nature of translatome array data. In this study, we confirm that polysome profiling yields skewed data and thus violates the conventional transcriptome analysis assumptions. Using a comprehensive simulation of translatome array data varying the percentage and symmetry of deregulation, we show that conventional analysis methods (Quantile and LOESS normalizations) and statistical tests failed, respectively, to correctly normalize the data and to identify correctly deregulated genes (DEGs). We thus propose a novel analysis methodology available as a CRAN package; Internal Control Analysis of Translatome (INCATome) based on a normalization tied to a group of invariant controls. We confirm that INCATome outperforms the other normalization methods and allows a stringent identification of DEGs. More importantly, INCATome implementation on a biological translatome data set (cells silenced for splicing factor PSF) resulted in the best normalization performance and an improved validation concordance for identification of true positive DEGs. Finally, we provide evidence that INCATome is able to infer novel biological pathways with superior discovery potential, thus confirming the benefits for researchers of implementing INCATome for future translatome studies as well as for existing data sets to generate novel avenues for research.

Indexed as

Protein BiosynthesisComputational BiologyComputer SimulationGene Expression ProfilingGene Expression RegulationHeLa CellsHigh-Throughput Nucleotide SequencingHumansOligonucleotide Array Sequence AnalysisPolyribosomesSequence Analysis, RNAmicroarray analysispolysome profilingtranslational regulationtranslatome

Identifiers

PMID28842509
PMCPMC5648029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.